IP Verse

Gh Research Ireland competitive analysis

Latest publications and patents of Gh Research Ireland New

Explore the latest publications and patents granted to Gh Research Ireland, showcasing their recent innovations and technological advancements.

Last updated on: Sep 25, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Gh Research Ireland

EP3927338
Oct 9, 2024Compositions Comprising 5-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) For Use In Treating Mental DisordersGranted And Under Opposition
EP3927337
Mar 20, 20245-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) For Treating DepressionGranted And Under Opposition
EP4313945
Mar 13, 2024Crastalline Hydrobromide Salt Of 5-Meo-DmtGranted And Under Opposition

Latest patents of Gh Research Ireland opposed by its competitors

Explore Gh Research Ireland's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3927338
Oct 9, 2024Compositions Comprising 5-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) For Use In Treating Mental Disorders1
EP3927337
Mar 20, 20245-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) For Treating Depression2
EP4313945
Mar 13, 2024Crastalline Hydrobromide Salt Of 5-Meo-Dmt1

Latest PTAB cases involving Gh Research Ireland

Discover the latest PTAB cases involving Gh Research Ireland, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Gh Research Ireland with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
GH RESEARCH IRELAND - 4 - - Non-Active
PORTA SOPHIA1 - 1 - Highly Aggressive
SCORPIO19 - - - Highly Aggressive
STRAWMAN329 - - - Highly Aggressive